Patents by Inventor Ben Roediger

Ben Roediger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES TARGETING IL-31
    Publication number: 20260167709
    Abstract: The invention relates to antibodies that bind to IL-31, including monospecific and multispecific e.g., bispecific antibodies, methods of producing the antibodies, pharmaceutical compositions comprising the antibodies, and methods of using the antibodies.
    Type: Application
    Filed: September 10, 2025
    Publication date: June 18, 2026
    Inventors: Regis CEBE, Hejun LIU, Frank KOLBINGER, Jiri KOVARIK, Kathrin MÜLLER, Ben ROEDIGER, Jean-Michel, René RONDEAU
  • Murine parvovirus and uses thereof
    Patent number: 11332720
    Abstract: The present disclosure relates to a novel murine parvovirus, sequences encoded thereby, and applications therefor. In one embodiment the disclosure provides a method for detecting the presence of a parvovirus in a sample, comprising detecting one or more nucleic acids or polypeptides derived from the parvovirus, or antibodies against the parvovirus, in the sample. Also provided are vectors and host cells comprising sequences encoded by the parvovirus and related sequences. Also provided are animal models of kidney disease associated with infection by the parvovirus.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: May 17, 2022
    Assignees: Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney
    Inventors: Ben Roediger, Wolfgang Weninger, Shweta Tikoo
  • NOVEL MURINE PARVOVIRUS AND USES THEREOF
    Publication number: 20200140829
    Abstract: The present disclosure relates to a novel murine parvovirus, sequences encoded thereby, and applications therefor. In one embodiment the disclosure provides a method for detecting the presence of a parvovirus in a sample, comprising detecting one or more nucleic acids or polypeptides derived from the parvovirus, or antibodies against the parvovirus, in the sample. Also provided are vectors and host cells comprising sequences encoded by the parvovirus and related sequences. Also provided are animal models of kidney disease associated with infection by the parvovirus.
    Type: Application
    Filed: May 25, 2018
    Publication date: May 7, 2020
    Inventors: Ben Roediger, Wolfgang Weninger, Shweta Tikoo